Home  > News  > Noteworthy

Noteworthy

Please find below news in brief from Ascenion, its partners and the technology transfer sector:

05.10.2017

Ascenion’s portfolio company OMEICOS extends Series B financing to address new indications

OMEICOS Therapeutics, a spin-off from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), announced the second closing of its Series B financing round with US-based REMIGES Ventures. The financing enables OMEICOS to establish a US-based subsidiary in Cambridge Massachusetts and to expand its technology into the field of eye diseases. The company plans to evaluate a range of compounds and different routes of administration for different types of eye diseases.

In the first quarter of 2017, OMEICOS reported the first closing of a Series B financing and initiated a Phase I trial with its lead compound OMT-28. So far, clinical development has focused on cardiovascular diseases, namely atrial fibrillation, the most common cardiac arrhythmia in humans.

For further information see:

OMEICOS press release

04.10.2017

In cooperation with TechnologieAllianz: Ascenion offers training courses

TechnologieAllianz is the German association for knowledge and technology transfer (KTT) and brings together universities, national research institutions and transfer service providers in a nationwide network. TechnologieAllianz is promoting the development and recognition of the KTT profession in Germany and is also striving towards sharing best practice among their members as well as with other international KTT institutions and networks worldwide. Additionally, TechnologieAllianz organises KTT training, workshops and conferences.

As a member of TechnologieAllianz, Ascenion will conduct two further-education training courses on the topic of equity management and one on contracts for research projects. 

Learn more

28.09.2017

Join BioFIT 2017, Europe’s Top Event for Public and Private Life-Science Collaborations

As a supporter of BioFIT Ascenion cordially invites all its partners to join this partnering event for open innovation, technology transfer and collaborative research in the life sciences, to take place on 28-29 November 2017 in Strasbourg, France.

BioFit brings together over 1,200 international leading stakeholders in the sector offering and seeking opportunities to

  • initiate new partnerships,
  • foster the emergence of collaborative projects, and
  • intensify the flow of licenses in the field of life sciences.


Further information:

Register!
Learn more!
Preliminary agenda

12.09.2017

BioEntrepreneurship Summit October 10-11, 2017, Munich

Get your earlybird ticket now!

Launching a life science or health tech venture is among the most complex and risky entrepreneurial undertaking, given extremely long development cycles, a strictly regulated approval process, high levels of technological and market uncertainty, and often extraordinary capital requirements. Technology convergence and the transformation of healthcare towards digital and personalized medicine enables entirely new products and services and paves the way for new business models but also poses a challenge for future or actual founders. BioEntrepreneurs largely profit from sector-specific support and specialized training and acceleration. They need to have access to experience in a multitude of disciplines as well as an extensive network to build sustainable ventures.

The BioEntrepreneurship Summit aims to bring together all relevant stakeholders of the bioentrepreneurial and health tech ecosystem.

Ascenion is partner of the BioEntrepreneurship Summit 2017. Get your earlybird ticket now at www.bioentrepeneurshipsummit.org

05.07.2017

Expansion of customer base

Three further research institutes have decided to enter into partnership with Ascenion in recent months. This brings the number of long-term partner institutes and associated organisations supported by Ascenion to a total of 30, including institutes of the Helmholtz and Leibniz Associations, universities and university clinics, as well as various other life-science oriented organizations.

The new partners are:

  • iba Heiligenstadt – Institute for Bioprocessing and Analytical Measurement Techniques e. V. (iba)
    The iba is a non-university research institute sponsored by the Free State of Thuringia. Its application-oriented scientific focus is on examining and changing interfaces between biological and technical components of functional systems for the life sciences.
    More information: www.iba-heiligenstadt.de
  • IMB Mainz – Institute of Molecular Biology gGmbH (IMB)
    The IMB is a centre of excellence funded by the Boehringer Ingelheim Foundation. Its research covers three key areas: developmental biology, epigenetics and DNA repair.
    More information: www.imb.de
  • ZMT Bremen – Leibniz Centre for Tropical Marine Research
    The ZMT is a Leibniz Association institute. Its aim is to analyse tropical coastal ecosystems in all their complexity and to create a scientific database to support their protection and sustainable use.
    More information: www.zmt-bremen.de

01.07.2017

Welcome to the team!

Ascenion has reinforced its Munich office team:

Marina Huber, who first joined Ascenion three years ago as a trainee for office management, has now successfully completed her training. She will continue to support the Munich Office in a permanent position as its friendly and reliable Team Assistant for general administration and PR-related projects.

Manuela Gruber joined Ascenion in July 2017. She has commercial training and brings many years of professional experience in various companies and sectors to the team, supporting Finance and Controlling at Ascenion’s headquarters.

29.06.2017

Biotech NetWorkshop – Where founders, experts and investors meet

Around thirty startup founders and aspiring entrepreneurs met in Munich during this year’s Biotech NetWorkshop to learn from drug development experts and discuss strategies for bringing innovative therapies to the market. This year Ascenion and Max Planck Innovation welcomed attendees and speakers from over seven European countries and ten leading life-science VC firms joined the event for the evening reception. In addition to the interactive talks, the workshop participants had excellent networking opportunities over the two-day program. In particular the reception kicked off with Professor of Life Sciences Law and Ethics Nils Hoppe’s outstanding and thought-provoking keynote, followed by the rooftop party with spectacular views over the city and the chance to mingle in a laid-back and fun atmosphere.

'I found the Biotech NetWorkshop to be extremely helpful in learning about the different facets of the biotech industry, including its regulatory aspects. I have made several great connections and I am very much looking forward to the next meeting,' says Dr Yuval Rinkevich, Head, Research Group - Cellular Therapeutics in Chronic Lung Disease - Helmholtz Zentrum München.

The next Biotech NetWorkshop will take place from 31 January – 2 February 2018 at Schloss Ringberg. More information on the program will be available later this year at www.biotech-networkshop.de.

26.06.2017

Jobs in technology transfer

A career in academia? Or maybe rather in industry? This is a question that preoccupies nearly every scientist at some point. But you can have the best of both worlds: people who work in technology transfer move in science and business circles. Dr Dior Baumjohann, Technology Manager at Ascenion, introduces the varied areas of activity of a technology manager in the current issue of BIOspektrum, and suggests possible starting points for scientists interested in learning more about career opportunities in technology transfer.

More information: article in the current issue of BIOspektrum
(only in German)

06.06.2017

Digital Health: Collaboration wanted

In the IBM DACH blog „Think“, Ascenion reports on the new possibilities and challenges in the area of digital health presented in the keynote talks at BioVaria. These include innovative ways to better diagnose and treat diseases, unique opportunities for interdisciplinary collaborations and the rapidly evolving dynamics of these markets.

Learn more here.
(only in German)

07.05.2017

10th BioVaria: Strong line-up of technologies, speakers and participants

Join Europe’s leading showcase for life-science inventions!

Ascenion is proud to present a strong line-up of speakers, participants and technologies for this year’s BioVaria Anniversary Edition to be held on 22 and 23 May 2017 in Munich.

  • Discover an unmatched density of commercially attractive licensing opportunities emanating from leading research institutes and renowned European universities.
  • Identify highly innovative, patent-protected technologies that fit your development needs: potential diagnostics and therapeutics, research tools as well as medical device technologies.
  • Meet representatives of 14 TTOs from 8 different European countries and scientists from 50 international research institutes for face-to-face discussion.

Get to know highly promising European life-science start-ups participating in this year´s Spin-off Panel.

Many ‘big names’ in the sector have registered already!
Don’t miss the opportunity!


Register here!

Explore the technologies presented in 10-min oral presentations and posters!

04.05.2017

Join us for the 11th Biotech NetWorkshop: 28-29 June 2017, Munich

Network with your peers, seasoned entrepreneurs and industry experts to gain valuable feedback on how to improve your project’s chances of success in a casual and fun environment.

Whether you are a company with a pipeline of preclinical assets, a nascent start-up or a researcher working on the next innovation on the verge of spinning out, this Biotech NetWorkshop is for you.

Learn how to take your idea into the clinic!

  • Explore the newest trends and strategies in the biopharma industry with an impressive line-up of speakers from big pharma, biotech, regulatory authorities and the investment community
  • Rooftop summer reception with confirmed participation of many leading VC firms plus biotech leaders
  • Keynote talk on “Lost in Translation: Ethical and Legal Pitfalls on the Way from Bench to Bedside” from Nils Hoppe, Professor of Life Sciences Law, Dean of Research, University of Hannover
  • Music, food, drinks and spectacular views of Munich

The event is jointly organized by Ascenion and Max Planck Innovation who have actively supported the foundation of over 80 spin-offs.

For further information:

Full program

Register now!

01.05.2017

Welcome to the team!

We are delighted to welcome Dr Ivana Dinulovic to Ascenion’s Munich Team, as of May this year. Alongside her specialist expertise in biochemistry, immunology and regenerative medicine, she brings international experience and knowledge in IP, and in patent and project management. After completing a degree in biochemistry in Serbia, she undertook a research visit to the USA and subsequently gained her PhD at the University of Basel’s Biozentrum.

As project manager for EU projects, Dr Dinulovic will initially be concentrating on the UTILE programme, working together closely with various colleagues at Ascenion and at three other leading European technology transfer organizations. The UTILE project supports the commercialization of EU-financed research projects in the context of the European research and innovation programme, Horizon 2020.

20.04.2017

No investment - no innovation: What technology transfer can do for Germany

The role of knowledge and technology transfer has developed considerably over the past few years. A contribution by Christian Stein in the recently published Ernst & Young German Biotechnology Report "Spot on Innovation" highlights the development of technology transfer in Germany and shows the importance of knowledge and technology transfer with regard to startups as well as in the development of new ideas and inventions from academia today and where there is potential for improvement.

Read more (only in German) "Spot on Innovation"

19.04.2017

TechnologieAllianz: Christian Stein has joined the Board of Directors

At the end of last year, Christian Stein was elected to the Board of Directors of TechnologieAllianz, the German Association for knowledge and technology transfer, and is now responsible for international cooperation and events.

Focusing on promoting the development and dissemination of professional standards for technology transfer, TechnologieAllianz will work together closely with the European association ASTP-Proton, to align the professional standards of the RTTP (Registered Technology Transfer Professional) established by the global association ATTP (Alliance of Technology Transfer Professionals).

In 2017, TechnologieAllianz will prioritize the training of technology transfer managers. This year, for example, about ten full-day training courses will be held by members for members. At the same time, planning for the Annual Conference 2018 which will focus on accelerating innovation through startups is in full swing.

TechnologieAllianz has set ambitious targets for the coming years. In order to achieve more impact and to better represent German technology transfer, they are planning to double the number of members from currently more than 50 members to at least 100.

Further information: Website TechnologieAllianz

03.04.2017

Charité BIH Entrepreneurship Summit, Berlin, May 8-9, 2017

Join over 400 fellow leaders in medical innovation to be part of the discussion to shape and address the biggest challenges and opportunities in healthcare today! During two conference days, you will get the opportunity to connect with entrepreneurs, scientists, physicians, investors, policymakers, and industry leaders from Germany, Europe, Israel, and the U.S. The agenda features inspiring keynotes and broad-ranging panel discussions on important topics such as new funding models for life science innovation, virtual and augmented reality in healthcare, and the future of healthy aging. Interactive workshops and the LifeSciences VentureMarket offer opportunities for entrepreneurs to learn about relevant strategic issues and to present their companies to international investors.

Ascenion is partner of the Charité Entrepreneurship Summit 2017. As member of our network you can save up to 33%. Please contact us!

Register here!

More information: www.charite-summit.de